Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Lula and Flavio Bolsonaro Tied in Brazil PollEldar Mansurov: Write a song first, then we'll see your serious musicFDA drug center head expected to leave after commissioner exitGladstone Land Q1 2026: Mixed ResultsMiddlesbrough issues statement on Championship spy scandalBlackRock Eyes $5-10B in SpaceX IPOEU starts Hormuz talks with IRGCUS May Prepare Operation to Capture Raul CastroRat Hepatitis E Detected in Hong KongBlackRock Eyes Multi-Billion Dollar Investment in SpaceX IPOLula and Flavio Bolsonaro Tied in Brazil PollEldar Mansurov: Write a song first, then we'll see your serious musicFDA drug center head expected to leave after commissioner exitGladstone Land Q1 2026: Mixed ResultsMiddlesbrough issues statement on Championship spy scandalBlackRock Eyes $5-10B in SpaceX IPOEU starts Hormuz talks with IRGCUS May Prepare Operation to Capture Raul CastroRat Hepatitis E Detected in Hong KongBlackRock Eyes Multi-Billion Dollar Investment in SpaceX IPO
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#innate-pharma

Latest news and interesting information about innate-pharma.

Innate Pharma Q1 2026 Beats Earnings Expectations
Today / 15:52
|
780

Innate Pharma Q1 2026 Beats Earnings Expectations

Innate Pharma Q1 2026 earnings beat forecasts: EPS surprise 5.82%, revenue up 13.43%, stock jumps 59.56%. Key catalysts include lacutamab, IPH4502, and monalizumab.

TRANSCRIPTS →
0
...